ArticleAmerican journal of translational research2023
The value of lung ultrasound in assessing the degree of lesions in children with mycoplasma pneumoniae pneumonia.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Lung Ultrasound Findings in Pediatric Mycoplasma Pneumoniae Pneumonia: A Prospective Multicenter Pilot Study.Children (Basel, Switzerland) · 2025Article
- The diagnostic value plasma procalcitonin (PCT) and serum amyloid A protein (SAA) in children with mycoplasma pneumonia.Journal of medical biochemistry · 2025Article
- Predictive value of an early comprehensive assessment model for refractory mycoplasma pneumoniae pneumonia and internal validation.BMC infectious diseases · 2025Article
- Biomarkers associated with the diagnosis and prognosis ofFrontiers in cellular and infection microbiology · 2025Review
- Distinguishing types and severity of pediatric pneumonia using modified lung ultrasound score.Frontiers in pediatrics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the value of lung ultrasound (LUS) in assessing the degree of lesions in children with mycoplasma pneumoniae pneumonia (MPP).
methodsThe clinical data of 100 children with pediatric MPP admitted to Jincheng General Hospital were retrospectively analyzed. Based on the standard of refractory MPP, the enrolled MPP-children were divided into refractory MPP group (n=25) and general MPP group (n=75). The general data were collected and compared between the two groups. The length of parenchymal lung lesions, the area in parenchymal lung lesions, and APACHE II scores were compared between the two groups. Logistic analysis was used to explore the risk factors that influence the extent of lesions in children with MPP. The receiver operating characteristic (ROC) curve was used to evaluate the ability of candidate indicators to predict the extent of lesions in children with MPP.
resultsLogistic regression equation analysis revealed that the length and area of parenchymal lung lesions were the factors influencing the extent of lesions in children with MPP (P<0.05). ROC curve showed that the AUC value of length of parenchymal lesions was 0.667, and the best sensitivity and specificity were 78.56% and 69.14%, respectively. The AUC value of area of parenchymal lesions was 0.582, and the best sensitivity and specificity were 58.19% and 81.04%, respectively.
conclusionLung ultrasound measurement of length and area of parenchymal lung lesions can be used to assess the extent of lesion in children with MPP and provide a basis for clinical treatment planning.
Indexed as
Identifiers
37056819PMC10086898What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.